PURPOSE: To compare ototoxicity rates between medulloblastoma patients treated with protons vs. photons. MATERIALS AND METHODS: The study included 84 children diagnosed with medulloblastoma treated with either passively scattered protons (n = 38) or photons (n = 46). Patients underwent maximal safe resection followed by craniospinal irradiation, posterior fossa and/or tumor bed boost and chemotherapy according to one of 3 multi-institutional trials. Median audiogram follow-up was 56 months for protons and 66 months for photons. RESULTS: Mean cochlear dose (Dmc) was lower in patients treated with protons for both standard (p < 0.0001) and high-risk disease (p < 0.001). Grade 3 and 4 ototoxicity was seen in 7 of 75 (9.3%) and 9 of 91 (9.9%) ears (Brock, p = 0.91), 13 of 75 (17.3%) and 19 of 91 (20.9%) ears (POG, p = 0.56), and 15 of 75 (20.0%) and 21 of 91 (23.1%) ears (SIOP Boston, p = 0.63) with protons and photons respectively. CONCLUSIONS: While cochlear doses were lower in the proton group, patients treated with either protons or photons had similar Grade 3 and 4 ototoxicity rates.
PURPOSE: To compare ototoxicity rates between medulloblastomapatients treated with protons vs. photons. MATERIALS AND METHODS: The study included 84 children diagnosed with medulloblastoma treated with either passively scattered protons (n = 38) or photons (n = 46). Patients underwent maximal safe resection followed by craniospinal irradiation, posterior fossa and/or tumor bed boost and chemotherapy according to one of 3 multi-institutional trials. Median audiogram follow-up was 56 months for protons and 66 months for photons. RESULTS: Mean cochlear dose (Dmc) was lower in patients treated with protons for both standard (p < 0.0001) and high-risk disease (p < 0.001). Grade 3 and 4 ototoxicity was seen in 7 of 75 (9.3%) and 9 of 91 (9.9%) ears (Brock, p = 0.91), 13 of 75 (17.3%) and 19 of 91 (20.9%) ears (POG, p = 0.56), and 15 of 75 (20.0%) and 21 of 91 (23.1%) ears (SIOP Boston, p = 0.63) with protons and photons respectively. CONCLUSIONS: While cochlear doses were lower in the proton group, patients treated with either protons or photons had similar Grade 3 and 4 ototoxicity rates.
Authors: David Y Mak; Zain Siddiqui; Zhihui Amy Liu; Hitesh Dama; Shannon M MacDonald; Shengjie Wu; Erin S Murphy; Matthew D Hall; Victor Malkov; Arzu Onar-Thomas; Sameera Ahmed; Girish Dhall; Derek S Tsang Journal: Pediatr Blood Cancer Date: 2022-04-04 Impact factor: 3.838
Authors: Maria E Goossens; Marc Van den Bulcke; Thierry Gevaert; Lydie Meheus; Dirk Verellen; Jean-Marc Cosset; Guy Storme Journal: Ecancermedicalscience Date: 2019-12-09
Authors: Sean M Liu; Eric D Brooks; M Laura Rubin; David R Grosshans; Steven J Frank; Mary Frances McAleer; Susan L McGovern; Arnold C Paulino; Kristina D Woodhouse Journal: Int J Part Ther Date: 2020-12-31
Authors: Enrico Franceschi; Caterina Giannini; Julia Furtner; Kristian W Pajtler; Sofia Asioli; Raphael Guzman; Clemens Seidel; Lidia Gatto; Peter Hau Journal: Cancers (Basel) Date: 2022-07-29 Impact factor: 6.575
Authors: Anita Mahajan; Helen Shih; Marta Penas-Prado; Keith Ligon; Kenneth Aldape; Leland S Hu; Ashlee R Loughan; Michael R Basso; Heather E Leeper; Brian V Nahed; Shannon L Stott; Susan Geyer; Caterina Giannini; Evanthia Galanis Journal: Cancers (Basel) Date: 2022-01-14 Impact factor: 6.575